Johnson & Johnson Stock Quote Today: $176.79 as of 2:38 PM EST

Johnson & Johnson (JNJ) Stock Performance: A Steady Giant

Johnson & Johnson, the multinational healthcare conglomerate, has consistently delivered strong financial performance, making it a favored choice among investors. Over the past year, JNJ stock has steadily climbed, reaching its current high of $176.79 as of 2:38 PM EST. This growth reflects the company's robust business model, diversified portfolio, and unwavering commitment to innovation.

Key Financial Highlights

• Revenue: $95.5 billion in 2022, a 3.6% increase from 2021
• Net income: $18.7 billion in 2022, a 4.3% increase from 2021
• Earnings per share (EPS): $10.20 in 2022, a 4.4% increase from 2021
• Dividend yield: 2.62% as of March 8, 2023, making it an attractive option for income-seeking investors

Growth Drivers: Innovation and Diversification

Johnson & Johnson's long-term success stems from its unwavering commitment to innovation and its diversified portfolio of businesses. The company invests heavily in research and development, with 10.9% of its revenue allocated to innovation-driving initiatives in 2022. This investment has fueled the development of innovative drugs, medical devices, and consumer healthcare products that meet the evolving needs of patients and consumers.

The company's diversified portfolio of businesses across pharmaceuticals, medical devices, and consumer healthcare provides stability and growth opportunities. In 2022, pharmaceuticals accounted for 54% of revenue, medical devices for 30%, and consumer healthcare for 16%. This diversification mitigates risks associated with any one business segment, ensuring long-term financial stability.

Bullish Market Outlook

Analysts remain bullish on Johnson & Johnson's stock, citing its strong fundamentals and growth prospects. The company projects revenue growth of 2-3% in 2023, driven by new product launches and continued demand for its core products. Additionally, the company's commitment to innovation and its strong balance sheet position it well for future growth opportunities.

Investment Considerations: Weighing the Pros and Cons

While Johnson & Johnson's stock has been a solid performer, investors should carefully consider the following factors before making an investment decision:

Pros:

• Strong and stable financial performance
• Diversified portfolio of businesses
• Commitment to innovation
• Attractive dividend yield

Cons:

• Slow growth compared to some competitors
• Potential for legal challenges and product recalls
• Exposure to macroeconomic factors such as inflation and currency fluctuations

Conclusion: A Solid Choice for Long-Term Investors

Johnson & Johnson's stock continues to be a solid choice for long-term investors seeking a combination of stability, growth, and income potential. The company's strong fundamentals, diversified portfolio, and commitment to innovation position it well for continued success in the years to come.

Additional Resources

• Johnson & Johnson Investor Relations
• Yahoo Finance: JNJ Stock Quote
• Seeking Alpha: JNJ Stock Analysis

**Tables**

Table 1: Johnson & Johnson Financial Highlights

Table 2: Johnson & Johnson Revenue Breakdown (2022)

Table 3: Johnson & Johnson Research and Development Expenditure

Table 4: Johnson & Johnson Projected Revenue Growth